Table 2 Univariate and multivariate analyses of different prognostic factors in patients with gliomas
From: Upregulation of SATB1 is associated with the development and progression of glioma
Variables | Relative risk (95% CI) | P-value |
|---|---|---|
Univariate | Â | Â |
Age | 0.794 (0.413-1.275) | 0.253 |
Sex | 0.715 (0.362-1.389) | 0.342 |
Tumor size | 0.932 (0.579-2.486) | 0.356 |
Tumor locus | 0.683 (0.362-1.142) | 0.182 |
Pathological grade | 1.854 (1.143-3.045) | 0.035 |
SATB1 | 0.448 (0.229-0.788) | 0.009 |
MGMT methylation | 0.224 (0.102-0.356) | 0.004 |
Multivariate | Â | Â |
Pathological grade | 0.654 (0.453-1.026) | 0.046 |
SATB1 | 0.446 (0.248-0.792) | 0.015 |
MGMT methylation | 0.412 (0.218-0.681) | 0.012 |